Where does EUCR stock trade?

Eucrates Biomedical Acquisition Corp. (EUCR) is listed on NASDAQ.

What sector and industry is EUCR in?

Eucrates Biomedical Acquisition Corp. operates in the Finance sector, Blank Checks industry.

When did Eucrates Biomedical Acquisition Corp. go public?

Eucrates Biomedical Acquisition Corp. (EUCR) completed its IPO in 2020.

What companies are similar to EUCR?

Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare EUCR side-by-side with any of them on Quantisnow.

How can I track EUCR on Quantisnow?

Quantisnow aggregates Eucrates Biomedical Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EUCR to receive live email and push alerts on every new disclosure.

EUCR

NASDAQ

Eucrates Biomedical Acquisition Corp.

SectorFinanceIndustryBlank ChecksIPO2020

$10.15+0.15 (+1.50%)

News25/Ratings0

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Latest news

25 items

1127dSEC
SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
15-12G - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1139dSEC
SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
25-NSE - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1152dSEC
SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1153dNEWS
Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today: The Company anticipates that it will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association. Accordingly, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association. As part of that dissolution and liquidation, the Company will redeem all of the outstanding ordinary shares that were included in its initial public offering (the "Public Shares") at a per-share redemption price of approximately $10.00. A
1154dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1154dPR
Eucrates Biomedical Acquisition Corp. Announces Liquidation
NEW YORK, April 11, 2023 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today: The Company anticipates that it will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association.Accordingly, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association.As part of that dissolution and liquidation, the Company will redeem all of the outstandi
1162dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1167dSEC
SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
NT 10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1208dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1214d13D/G
SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
SC 13G/A - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1302dSEC
SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.
10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1307d13D/G
SEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.
SC 13G - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1308dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1316dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1323dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1335dSEC
SEC Form DEF 14A filed by Eucrates Biomedical Acquisition Corp.
DEF 14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1342dSEC
SEC Form PRER14A filed by Eucrates Biomedical Acquisition Corp.
PRER14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1349dSEC
SEC Form PRE 14A filed by Eucrates Biomedical Acquisition Corp.
PRE 14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1393dSEC
SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.
10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1477dSEC
SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.
10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1484dSEC
SEC Form NT 10-Q filed by Eucrates Biomedical Acquisition Corp.
NT 10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1522dSEC
SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1530dSEC
SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
NT 10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1575d13D/G
SEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.
SC 13G - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1581d13D/G
SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
SC 13G/A - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)

EUCR FAQ

6 questions

What does Eucrates Biomedical Acquisition Corp. do?
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Where does EUCR stock trade?
Eucrates Biomedical Acquisition Corp. (EUCR) is listed on NASDAQ.
What sector and industry is EUCR in?
Eucrates Biomedical Acquisition Corp. operates in the Finance sector, Blank Checks industry.
When did Eucrates Biomedical Acquisition Corp. go public?
Eucrates Biomedical Acquisition Corp. (EUCR) completed its IPO in 2020.
What companies are similar to EUCR?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare EUCR side-by-side with any of them on Quantisnow.
How can I track EUCR on Quantisnow?
Quantisnow aggregates Eucrates Biomedical Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EUCR to receive live email and push alerts on every new disclosure.